Advertisement

Relationship of Coxsackievirus to Cardiac Autoimmunity

  • Kirk W. Beisel
  • Noel R. Rose
Part of the Infectious Agents and Pathogenesis book series (IAPA)

Abstract

For many years, a relationship between viral infection and the development of autoimmunity has been suspected in diseases such as diabetes mellitus,1–3 multiple sclerosis,45 idiopathic thrombocytopenia purpura,6 chronic active hepatitis,7 postmeasles encephalitis,8,9 and myocarditis.10,12 During the past decade, significant strides have been made in developing an understanding of this intricate and involved relationship. Some of the most studied experimental models are encephalomyocarditic virus-induced and coxsackievirus B4 (CVB4)-induced diabetes mellitus in mice, which have been investigated by Notkins and Yoon and colleagues.1,13–15 Their studies have shown that both the genetics of the host and the infectious agent determine the host’s susceptibility to viral infection, the virus-induced pathology, and the development of autoimmune disease. These investigators have also attempted to clarify the relationship of the virus with organ-specific autoimmunity by hybridizing antibody-forming cells of infected mice. Multiple organ-reactive monoclonal antibodies were produced in the wake of a reovirus infection.16–17 These studies also demonstrated that there are sometimes shared epitopes between the virus and host tissues.

Keywords

Viral Myocarditis Serum Pool Cardiac Myosin Normal Mouse Serum CVB3 Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Yoon, J. W., 1983, Viruses in the pathogenesis of type I diabetes, Curr. Probl. Clin. Biochem. 12:11–44.PubMedGoogle Scholar
  2. 2.
    Brogen, C. H., Baekkeskov, S., Dyrberg, T., Lenmark, A., Marner, B., Nerup, J., and Papadopoulos, G. K., 1983, Role of islet cell antibodies in the pathogenesis of type I diabetes, Curr. Probl. Clin. Biochem. 12:65–95.Google Scholar
  3. 3.
    Gepts, W., 1983, Role of cellular immunity in the pathogenesis of type I diabetes, Curr. Probl. Clin. Biochem. 12:86–107.PubMedGoogle Scholar
  4. 4.
    Waksman, B. H., and Reynolds, W. E., 1984, Multiple sclerosis as a disease of immune regulation, Proc. Soc. Exp. Biol. Med. 175:282–294.PubMedGoogle Scholar
  5. 5.
    Waksman, B. H., 1983, Immunity and nervous system: Basic tenets, Ann. Neurol. 13:517–591.CrossRefGoogle Scholar
  6. 6.
    Pini, M., Potli, R., and Dettori, A. G., 1982, Purpura thrombotic thrombocytopenia, Recent Prog. Med. 73:429–442.Google Scholar
  7. 7.
    Sherlock, S., 1984, Chronic hepatitis and cirrhosis, Hepatology 4:25–28.CrossRefGoogle Scholar
  8. 8.
    Moench, T. R., and Griffin, D. E., 1984, Immunocytochemical identification and quantification of the mononuclear cells in the cerebrospinal fluid, meninges and brain during acute viral meningoencephalomyelitis, J. Exp. Med. 159:77–88.PubMedCrossRefGoogle Scholar
  9. 9.
    Johnson, R. T., Griffin, D. E., Hirsh, R. L. Wolinsky, J. S., Roedenbeck, S., Soriano, I. L. de, and Vaisberg, B., 1984, Measles encephalomyelitis—Clinical immunologic studies, N. Engl. J. Med. 310:137–141.PubMedCrossRefGoogle Scholar
  10. 10.
    Abelman, W. H., 1971, Virus and the heart, Circulation 44:950–956.Google Scholar
  11. 11.
    Maisch, B., Berg, P. A., and Kochsiek, K., 1980, Autoantibodies and serum inhibition factors (SIF) in patients with myocarditis, Klin. Wochenschr, 58:219–225.PubMedCrossRefGoogle Scholar
  12. 12.
    Maisch, B., Trostel-Soeder, R., Stechemesser, E., Berg, P. D., and Kochsiek, K., 1982, Diagnostic prevalence of humoral and cell-mediated immune reactions in patients with acute viral myocarditis, Circulation 70:149–156.Google Scholar
  13. 13.
    Yoon, J. W., and Notkins, A. L., 1976, Virus-induced diabetes mellitus. VI. Genetically determined host differences in the replication of encephalomyocarditis virus in pancreatic beta cells, J.Exp. Med. 143:1170–1185.CrossRefGoogle Scholar
  14. 14.
    Yoon, J. W., Onodera, T., and Notkins, A. L., 1978, Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with Coxsackie virus B4,J.Exp. Med. 148:1068–1080.PubMedCrossRefGoogle Scholar
  15. 15.
    Onodera, T., Tonioio, A., Ray, U. R., Jenson, A. B., Knazek, R. A., and Notkins, A. L., 1981, Virus-induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity,J.Exp. Med. 153:1457–1473.PubMedCrossRefGoogle Scholar
  16. 16.
    Haspel, M. V., Onodera, T., Prabhakar, B. S., Horita, M. S., and Notkins, A. L., 1983, Virus-induced autoimmunity: Monoclonal antibodies that react with endocrine glands, Science 220:304–306.PubMedCrossRefGoogle Scholar
  17. 17.
    Notkins, A. L., and Prabhakar, B. S., 1986, Monoclonal autoantibodies that react with multiple organs. Basis for reactivity, Ann. NY Acad. Sci 475:123–134.PubMedCrossRefGoogle Scholar
  18. 18.
    Hirsh, M. S., and Proffitt, M. R., 1975, Autoimmunity in viral infections, in: Viral Immunology and Immunopathology (A. L. Notkins, ed.), pp. 419–434, Academic, New York.Google Scholar
  19. 19.
    Notkins, A. L., Onodera, T., and Prabhakar, B., 1984, Virus-induced autoimmunity, in: Concepts in Viral Pathogenesis (A. L. Notkins and M. B. A. Oldstone, eds.), pp. 210 – 215, Springer-Verlag, New York.CrossRefGoogle Scholar
  20. 20.
    Plotz, P. H., 1983, Autoantibodies are anti-idiotype antibodies to antiviral antibodies, Lancet 2:824–826.PubMedCrossRefGoogle Scholar
  21. 21.
    Woodruff, J. F., 1970, Viral myocarditis, Am. J. Pathol. 101:427–479.Google Scholar
  22. 22.
    Sainani, G. S., Krompotic, E., and Slodki, S. J., 1968, Adult heart disease due to Coxsackie B infection, Medicine (Baltimore) 47:133–147.CrossRefGoogle Scholar
  23. 23.
    Cambridge, G., MacArthur, C. G. C., Waterson, A. P., Goodwin, J. F., and Oakley, C. M., 1979, Antibodies to Coxsackie B viruses in primary congestive cardiomyopathy, Br. Heart J. 41:692–696.PubMedCrossRefGoogle Scholar
  24. 24.
    MacArthur, C. G. C., Tarin, D., Goodwin, J. F., and Hallidie-Smith, K. A., 1984, The relationship of myocarditis to dilated cardiomyopathy, Eur. Heart J. 5:1023–1035.PubMedGoogle Scholar
  25. 25.
    Helin, M., Savola, J., and Lapinleimu, K., 1968, Cardiac manifestations during a Coxsackie B5 epidemic, Br. Med. J. 3:97–99.PubMedCrossRefGoogle Scholar
  26. 26.
    Kaplan, M. H., and Frengley, J. D., 1969, Autoimmunity to the heart in cardiac disease, current concepts of the relation to autoimmunity to rheumatic fever, postcar-diotomy, and postinfarction syndromes and cardiomyopathies, Am. J. Cardiol. 24:459–473.PubMedCrossRefGoogle Scholar
  27. 27.
    Maisch, B., Deeg, P., Liebau, G., and Kochsiek, K. 1976, Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy, Am. J. Cardiol. 52:1072–1078.CrossRefGoogle Scholar
  28. 28.
    Scheerder, I. de, Vandekerckhove, J., Robbrecht, J., Algoed, L., Buyzere, M. de, Langhe, J. de, Schrijver, G. de, and Clement, D., 1985, Post-cardiac injury syndrome and an increased humoral immune response against the major contractile proteins (actin and myosin), Am. J. Cardiol. 56:631–633.PubMedCrossRefGoogle Scholar
  29. 29.
    Das, S. K., Callen, J. P., Dodson, V. N., and Cassidy, J. T., 1971, Immunoglobulin binding in cardiomyopathic hearts, Circulation 44:612–616.PubMedGoogle Scholar
  30. 30.
    Schultheiss, H. P., and Boite, H. D., 1985, Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy, J. Mol. Cell. Cardiol. 17:603–617.PubMedCrossRefGoogle Scholar
  31. 31.
    Wong, C. Y., Woodruff, J. J., and Woodruff, J. F., 1977, Generation of cytotoxic T-lymphocytes during Coxsackie B3 infection. II. Characterization of effector cells and demonstration of cytotoxicity against viral-infected myocytes,J. Immunol. 118:1165–1169.PubMedGoogle Scholar
  32. 32.
    Guthrie, M., Lodge, P. A., and Huber, S. A., 1984, Cardiac injury in myocarditis induced by Coxsackievirus group B in Balb/c mice is mediated by Lyt 2+ cytolytic lymphocytes, Cell. Immunol. 88:558–567.PubMedCrossRefGoogle Scholar
  33. 33.
    Job, L. P., Lyden, D. C., and Huber, S. A., 1986, Demonstration of suppressor cells in Coxsackievirus group B, type 3 infected female Balb/c mice which prevent myocarditis, Cell. Immunol. 9:104–113.CrossRefGoogle Scholar
  34. 34.
    Huber, S. A., and Lodge, P. A., 1986, Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice, Am. J. Pathol. 122:284–291.PubMedGoogle Scholar
  35. 35.
    Khatib, R., Chason, J. L., Silberberg, B. K., and Lerner, A. M., 1980, Age-dependent myocardial pathogenesis of group B Coxsackievirus in Swiss-Webster mice: Comparisons to the pancreas,J. Infect. Dis. 141:394–401.PubMedCrossRefGoogle Scholar
  36. 36.
    Gauntt, C. J., Trousdale, M. D., LaBadie, D. R. L., Paque, R. E., and Nealson, T., 1979, Properties of Coxsackievirus which are amyocarditic and myocarditic for mice,J. Med. Virol. 3:207–220.PubMedCrossRefGoogle Scholar
  37. 37.
    Wolfgram, L. J., Beisel, K. W., and Rose, N. R., 1986, Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among strains of mice,J. Immunol. 136:1846–1852.PubMedGoogle Scholar
  38. 38.
    Herskowitz, A., Wolfgram, L. J., Rose, N. R., and Beisel, K. W., 1987, Coxsackievirus B3 murine myocarditis—Pathologic spectrum of myocarditis in genetically defined inbred strains,J.Am. Coll. Cardiol. 9:1311–1319.PubMedCrossRefGoogle Scholar
  39. 39.
    Beisel, K., Wolfgram, L., Herskowitz, A., and Rose, N., 1985, Differences in severity of Coxsackievirus B3-induced myocarditis among H-2 congenic mouse strains, in: Genetic Control of Resistance to Infection and Malignancy (E. Skamene, ed.), pp. 195–201, Alan R. Liss, New York.Google Scholar
  40. 40.
    Wolfgram, L. J., Beisel, K. W., and Rose, N. R., 1985, Heart-specific autoantibodies following murine Coxsackievirus B3 myocarditis,J.Exp. Med. 161:1112–1121.PubMedCrossRefGoogle Scholar
  41. 41.
    Matsumori, A., and Kawai, C., 1982, Animal model of congestive (dilated) cardiomyopathy: Dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus, Circulation 66:355–360.PubMedCrossRefGoogle Scholar
  42. 42.
    Reyes, M. R., Khang-Loon, H., Smith, F., and Lerner, A. M., 1981, A mouse model of dilated-type cardiomyopathy due to Coxsackievirus B3,J. Infect. Dis. 144:232–236.PubMedCrossRefGoogle Scholar
  43. 43.
    Alvarez, F. L., Neu, N., Rose, N. R., Craig, S. W., and Beisel, K. W., 1987, Heartspecific autoantibodies induced by Coxsackievirus B3: Identification of heart autoantigens, Clin. Immunol. Immunopathol. 43:129–139.PubMedCrossRefGoogle Scholar
  44. 44.
    Neu, N., Beisel, K. W., Traystman, M. D., Rose, N. R., and Craig, S. W., 1987, Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis,J. Immunol. 138:2488–2492.PubMedGoogle Scholar
  45. 45.
    Neu, N., Rose, N. R., Beisel, K. W., Herskowitz, A., Gurri-Glass, G., and Craig, S. W., 1987, Cardiac myosin induces myocarditis in genetically predisposed mice,J. Immunol. 139:3630–3636.PubMedGoogle Scholar
  46. 46.
    Rose, N. R., Beisel, K. W., Herskowitz, A., Neu, N., Wolfgram, L. J., Alvarez, F. L., Traystman, M. D., and Craig, S. W., 1987’, Autoimmunity and Autoimmune Disease: Ciba Foundation Symposium 129 (D. Evered and J. Whelan, eds.), pp. 3–24, John Wiley & Sons, Chichester, England.Google Scholar
  47. 47.
    Beisel, K. W., Tharpe, J. A., Sell, K. W., Notkins, A. L., and Prabhakar, B. S., 1987, A monoclonal antibody against Coxsackievirus B4 which cross-reacts with the V1 isoform of myosin: implication for autoimmunity, J. Am. Coll. Cardiol. 9:145A.Google Scholar
  48. 48.
    Cunningham, M. W., Hall, N. K., Krisher, K. K., and Spanier, A. M., 1986, A study of anti-group A streptococcal monoclonal antibodies crossreactive with myosin,J. Immunol. 136:293–298.PubMedGoogle Scholar
  49. 49.
    Dale, J. B., and Beachey, E. H., 1985, Epitopes of streptococcal M proteins shared with cardiac myosin,J.Exp. Med. 162:583–591.PubMedCrossRefGoogle Scholar
  50. 50.
    Neu, N., Craig, S. W., Rose, N. R., Alvarez, F., and Beisel, K. W., 1987, Coxsackievirus-induced myocarditis in mice: Cardiac myosin autoantibodies do not crossreact with the virus, Clin. Exp. Immunol. 69:566–574.PubMedGoogle Scholar
  51. 51.
    Wolfgram, L. J., 1986, Variations in the susceptibility to Coxsackievirus B3 induced myocarditis among different strains of mice, Ph.D. dissertation, Johns Hopkins University, Baltimore, Maryland.Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Kirk W. Beisel
    • 1
  • Noel R. Rose
    • 2
  1. 1.Department of Pathology and Laboratory MedicineEmory University School of MedicineAtlantaUSA
  2. 2.Department of Immunology and Infectious Diseases, School of Hygiene and Public HealthThe Johns Hopkins UniversityBaltimoreUSA

Personalised recommendations